Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Axcella Health Inc (NQ: AXLA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axcella Health Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Axcella's NASH Candidate Shows Favorable Action In Long COVID-Related Fatigue
Via Benzinga
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
From Axcella Therapeutics
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. 
Via Benzinga
Recap: Axcella Health Q1 Earnings
Axcella Health (NASDAQ:AXLA) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Axcella Health: Q4 Earnings Insights
  Axcella Health (NASDAQ:AXLA) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
89 Biggest Movers From Friday
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
From Axcella Therapeutics
Via Business Wire
Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
From Axcella Therapeutics
Via Business Wire
Axcella Reports First Quarter Financial Results and Provides Business Update
From Axcella Therapeutics
Via Business Wire
Earnings Scheduled For March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
From Axcella Therapeutics
Via Business Wire
Preview: Axcella Health's Earnings
Axcella Health (NASDAQ:AXLA) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Axcella... 
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. 
Via Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,  
Via Benzinga
Axcella Health Earnings Conference Call Is Coming Up, Here's What You Need To Know
Axcella Health (NASDAQ:AXLA) will host a conference call at 08:30 AM ET on March 30, 2022, to discuss Q4 2021 earnings results. How to Attend Axcella Health (AXLA) Conference Call... 
Via Benzinga
Axcella to Report Fourth Quarter and Year End 2021 Financial Results on March 30, 2022
From Axcella Therapeutics
Via Business Wire
Executives Buy Around $16M Of 4 Penny Stocks
US stocks closed higher with the Nasdaq Composite jumping over 2% on Friday. Investors, meanwhile, focused on some notable insider trades 
Via Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... 
Via Benzinga
Insiders Buy Over $7M Of 3 Penny Stocks
The US Federal Reserve, on Wednesday, raised its target fed funds rate by 0.25%, its first interest rate hike since 2018. Investors, meanwhile, focused on some notable insider trades 
Via Benzinga
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At The Market
From Axcella Therapeutics
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers TherapeuticsMD (NASDAQ:TXMD) stock increased by 56.5% to $0.33 during Monday's pre-market session. The company's market cap stands at $139.7 million.... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Kaleido Biosciences (NASDAQ:KLDO) stock rose 14.6% to $1.73 during Friday's pre-market session. The market value of their outstanding shares is at $73.6... 
Via Benzinga
Axcella Therapeutics Announces FDA Fast Track Designation for AXA1125 in NASH
From Axcella Therapeutics
Via Business Wire
Axcella Therapeutics to Participate in the SVB Leerink Global Healthcare Conference
From Axcella Therapeutics
Via Business Wire
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
From Axcella Therapeutics
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.